Vitamin D Deficiency among HIV Type 1-Infected Individuals in the Netherlands: Effects of Antiretroviral Therapy

被引:128
作者
Van Den Bout-Van Den Beukel, Carolien J. P.
Fievez, Lydia
Michels, Meta
Sweep, Fred C. G. J.
Hermus, Ad R. M. M.
Bosch, Marjolein E. W.
Burger, David M.
Bravenboer, Bert [2 ]
Koopmans, Peter P.
Van Der Ven, Andre J. A. M. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, NUCI Int Hlth, NL-6500 HB Nijmegen, Netherlands
[2] Catharina Hosp, Dept Gen Internal Med, Eindhoven, Netherlands
关键词
D O I
10.1089/aid.2008.0058
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vitamin D regulates bone metabolism but has also immunoregulatory properties. In HIV-infected patients bone disorders are increasingly observed. Furthermore, low 1,25(OH)(2)D-3 levels have been associated with low CD4+ counts, immunological hyperactivity, and AIDS progression rates. Few studies have examined the vitamin D status in HIV-infected patients. This study will specifically focus on the effects of antiretroviral agents on vitamin D status. Furthermore, the effect of vitamin D status on CD4 cell recovery after initiation of HAART will be evaluated. Among 252 included patients the prevalence of vitamin D deficiency (<35 nmol/liter from April to September and <25 nmol/liter from October to March) was 29%. Female sex, younger age, dark skin, and NNRTI treatment were significant risk factors in univariate analysis, although in multivariate analyses skin pigmentation remained the only independent risk factor. Median 25(OH)D-3 levels were significantly lower in white NNRTI-treated patients [54.5(27.9-73.8) nmol/liter] compared to white PI-treated patients [77.3 (46.6-100.0) nmol/liter, p = 0.007], while among nonwhites no difference was observed. Both PI-and NNRTI-treated patients had significantly higher blood PTH levels than patients without treatment. Moreover, NNRTI treatment puts patients at risk of elevated PTH levels (>6.5 pmol/liter). Linear regression analysis showed that vitamin D status did not affect CD4 cell recovery after initiation of HAART. In conclusion, 29% of the HIV-1-infected patients had vitamin D deficiency, with skin color as an independent risk factor. NNRTI treatment may add more risk for vitamin D deficiency. Both PI-and NNRTI-treated patients showed higher PTH levels and might therefore be at risk of bone problems. Evaluation of 25( OH) D3 and PTH levels, especially in NNRTI-treated and dark skinned HIV-1-infected patients, is necessary to detect and treat vitamin D deficiency early.
引用
收藏
页码:1375 / 1382
页数:8
相关论文
共 26 条
[1]  
Amorosa V, 2006, CLIN INFECT DIS, V42, P108, DOI 10.1086/498511
[2]   Immunological recovery and antiretroviral therapy in HIV-1 infection [J].
Battegay, M ;
Nuesch, R ;
Hirschel, B ;
Kaufmann, GR .
LANCET INFECTIOUS DISEASES, 2006, 6 (05) :280-287
[3]   CORRELATION OF SEASONAL-VARIATION OF 25-HYDROXYCALCIFEROL WITH UV-RADIATION DOSE [J].
BEADLE, PC ;
BURTON, JL ;
LEACH, JF .
BRITISH JOURNAL OF DERMATOLOGY, 1980, 103 (03) :289-293
[4]   Vitamin D status and its relation to age and body mass index [J].
Bischof, Martin G. ;
Heinze, Georg ;
Vierhapper, Heinrich .
HORMONE RESEARCH, 2006, 66 (05) :211-215
[5]   RIFAMPICIN AND VITAMIN-D METABOLISM [J].
BRODIE, MJ ;
BOOBIS, AR ;
DOLLERY, CT ;
HILLYARD, CJ ;
BROWN, DJ ;
MACINTYRE, I ;
PARK, BK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (06) :810-814
[6]   EFFECT OF RIFAMPICIN AND ISONIAZID ON VITAMIN-D METABOLISM [J].
BRODIE, MJ ;
BOOBIS, AR ;
HILLYARD, CJ ;
ABEYASEKERA, G ;
STEVENSON, JC ;
MACINTYRE, I ;
PARK, BK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (04) :525-530
[7]   Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review [J].
Brown, Todd T. ;
Qaqish, Roula B. .
AIDS, 2006, 20 (17) :2165-2174
[8]  
*CDC, 1992, MMWR, V41
[9]   MICRONUTRIENT CONCENTRATIONS IN THE HIV WASTING SYNDROME [J].
COODLEY, GO ;
COODLEY, MK ;
NELSON, HD ;
LOVELESS, MO .
AIDS, 1993, 7 (12) :1595-1600
[10]   HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D [J].
Cozzolino, M ;
Vidal, M ;
Arcidiacono, MV ;
Tebas, P ;
Yarasheski, KE ;
Dusso, AS .
AIDS, 2003, 17 (04) :513-520